Merck&Co. completed Q2 2010 with a 52% decline in net profit

In the II quarter of 2010, the net profit of the American pharmaceutical company Merck & Co. decreased by 52% due to increased costs, in particular administrative and restructuring, as well as a sharp decrease in profits from partnerships.

Leave a Comment

Your email address will not be published. Required fields are marked *